Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
MY-004 by Createrna Science and Technology for Atopic Dermatitis (Atopic Eczema): Likelihood of Approval
MY-004 is under clinical development by Createrna Science and Technology and currently in Phase II for Atopic Dermatitis (Atopic Eczema)....
MY-004 by Createrna Science and Technology for Systemic Lupus Erythematosus: Likelihood of Approval
MY-004 is under clinical development by Createrna Science and Technology and currently in Phase II for Systemic Lupus Erythematosus. According...
MY-004 by Createrna Science and Technology for Psoriasis: Likelihood of Approval
MY-004 is under clinical development by Createrna Science and Technology and currently in Phase II for Psoriasis. According to GlobalData,...